0001437749-24-007349.txt : 20240311
0001437749-24-007349.hdr.sgml : 20240311
20240311180018
ACCESSION NUMBER: 0001437749-24-007349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WOLF KENNETH
CENTRAL INDEX KEY: 0001224452
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15701
FILM NUMBER: 24739464
MAIL ADDRESS:
STREET 1: 12626 HIGH BLUFF DRIVE
STREET 2: SUITE 440
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC
CENTRAL INDEX KEY: 0000787253
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 841007839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1535 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008-7319
BUSINESS PHONE: 7607367700
MAIL ADDRESS:
STREET 1: 1535 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008-7319
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC
DATE OF NAME CHANGE: 19860929
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-03-07
0000787253
NATURAL ALTERNATIVES INTERNATIONAL INC
NAII
0001224452
WOLF KENNETH
1535 FARADAY AVENUE
CARLSBAD
CA
92008
1
President, COO, & Sec.
0
Common Stock
2024-03-07
4
F
0
6533
5.95
D
125053
D
Common Stock
2024-03-08
4
A
0
14500
0
A
139553
D
This transaction represents a resale of 6,533 shares to the Issuer as payment of the reporting person's tax liability upon vesting of 11,667 shares of restricted stock on March 7, 2024, using the closing stock price on March 7, 2024, of $5.95 per share.
This transaction represents a grant of restricted stock pursuant to the Issuer's 2020 Omnibus Incentive Plan.
One third (4,834 shares) of the restricted stock vests on March 7, 2025; one third (4,833 shares) of the restricted stock vests on March 7, 2026, and the final third (4,833 shares) of the restricted stock vests on March 7, 2027.
/s/ Kenneth E. Wolf
2024-03-11